Parkman Healthcare Partners’s Compass Pathways CMPS Stock Holding History
Bought
Maintained
Sold
Other funds holding CMPS
DTC
RI
TCM
BC
AIM
GC
DCM
Parkman Healthcare Partners's CMPS Position: Q1 2026 in Review
Parkman Healthcare Partners increased its Compass Pathways (CMPS) stake by 457% in Q1 2026, buying an estimated $3.06M and bringing the position to 554,411 shares worth $3.07M. The position accounts for 0.32% of the portfolio, ranked #76.
Parkman Healthcare Partners first reported a position in CMPS in Q3 2025 and has held it in 3 quarters since. 194 funds tracked by Wall St. Rank hold CMPS as of Q1 2026.
- Parkman Healthcare Partners held 554,411 shares of Compass Pathways worth $3.07M as of Q1 2026.
- Parkman Healthcare Partners bought 454,939 Compass Pathways shares in Q1 2026, an estimated $3.06M.
- Compass Pathways made up 0.32% of Parkman Healthcare Partners's portfolio in Q1 2026, its #76 holding.
- Parkman Healthcare Partners first reported a position in Compass Pathways in Q3 2025 and has held it in 3 quarters since.
- 194 funds tracked by Wall St. Rank held Compass Pathways as of Q1 2026.
Based on Parkman Healthcare Partners's 13F filing for Q1 2026, filed 15 May 2026.